Zepbound Insurance Coverage

Direct Answer

Zepbound coverage for obesity varies by payer and plan, similar to Wegovy, requiring prior authorization with standard BMI-based criteria. Zepbound also carries a separate, FDA-approved obstructive sleep apnea indication, which often opens a real, distinct, sometimes more reliable coverage pathway, particularly on Medicare Advantage plans.

Medicare Specifically

As of April 2026, Humana and other Medicare Advantage plans began covering Zepbound for obesity directly under the Treat and Reduce Obesity Act, at a capped copay. The Medicare GLP-1 Bridge Program, starting July 2026, also covers Zepbound (KwikPen specifically) for weight loss at $50/month.

Coverage varies by specific plan, employer, and state. This information reflects publicly available data as of August 2026.

Browse Coverage by Payer

• UnitedHealthcare GLP-1 Insurance Coverage
• Blue Cross Blue Shield GLP-1 Insurance Coverage
• Aetna GLP-1 Insurance Coverage
• Cigna GLP-1 Insurance Coverage
• Humana GLP-1 Insurance Coverage
• Medicare GLP-1 Insurance Coverage
• Medicaid GLP-1 Insurance Coverage

Browse All Insurance Coverage

See the complete GLP-1 Insurance Coverage hub

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com